Bulletin
Investor Alert

New York Markets Open in:

Tiziana Life Sciences Ltd.

NAS: TLSA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 29, 2023, 7:51 p.m.

/zigman2/quotes/207307745/composite

$

0.62

Change

+0.01 +1.64%

Volume

Volume 2,150

Quotes are delayed by 20 min

/zigman2/quotes/207307745/composite

Previous close

$ 0.63

$ 0.61

Change

-0.02 -2.87%

Day low

Day high

$0.60

$0.64

Open

52 week low

52 week high

$0.50

$1.39

Open

Annual Financials for Tiziana Life Sciences Ltd.

Operating Activities

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Net Income before Extraordinaries (9.88M)(10.01M)(28.3M)(26.66M)(15.4M)
Depreciation, Depletion & Amortization 16,001252,59691,047141,00051,000
Depreciation and Depletion 16,001252,59691,047141,00051,000
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 3.32M2.68M16.58M5.53M(3.11M)
Funds from Operations (6.54M)(7.08M)(11.63M)(20.99M)(18.45M)
Extraordinaries -----
Changes in Working Capital 1.94M287,041(293,659)(773,000)(1.16M)
Receivables (180,010)(127,574)(466,777)428,000(156,000)
Accounts Payable -----
Other Assets/Liabilities 2.12M414,615173,118(1.2M)(1.01M)
Net Operating Cash Flow (4.6M)(6.79M)(11.92M)(21.76M)(19.62M)

Investing Activities

20182019202020212022 5-year trend
Capital Expenditures -(3,827)(126,953)(22,000)-
Capital Expenditures (Fixed Assets) -(3,827)(2,565)(22,000)-
Capital Expenditures (Other Assets) --(124,388)--
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments ----(2.68M)
Purchase of Investments ----(2.68M)
Sale/Maturity of Investments -----
Other Uses ----(1.32M)
Other Sources ---152,000-
Net Investing Cash Flow -(3,827)(126,953)130,000(4M)

Financing Activities

20182019202020212022 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 10.09M1.88M73.96M129,000-
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 10.09M1.88M73.96M129,000-
Proceeds from Stock Options 8.58M-69.44M--
Other Proceeds from Sale of Stock 1.51M1.88M4.53M129,000-
Issuance/Reduction of Debt, Net -----
Change in Current Debt -----
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 10.09M1.68M73.68M(23,000)(55,000)
Exchange Rate Effect ---(1.98M)(398,000)
Miscellaneous Funds -----
Net Change in Cash 5.49M(5.12M)61.64M(23.64M)(24.06M)
Free Cash Flow (4.6M)(6.8M)(11.92M)(21.78M)(19.62M)
Link to MarketWatch's Slice.